How do anaesthesiologists treat malignant hyperthermia in a full-scale anaesthesia simulator?
BACKGROUND
Clinical malignant hyperthermia (MH) is rare and usually occurs unexpectedly. Prompt diagnosis and correct treatment is crucial for survival of the patient developing fulminant MH. The aims of the present study were to investigate whether anaesthesiologists could make a correct diagnosis of MH and to evaluate their treatment of fulminant MH in a simulator.


METHODS
Thirty-two teams (one anaesthesiologist/one nurse anaesthetist) were exposed to an event of clinical MH in a full-scale simulator. Their performance was videotaped for retrospective analysis of the treatment on the basis of the recommendations of the Danish Malignant Hyperthermia Register.


RESULTS
All 32 teams asked the surgeon to terminate the surgery as fast as possible, switched off the vaporiser and administered 100% oxygen. Although all intended to hyperventilate the patient, only 14 teams actually managed to perform the hyperventilation. Most problems were found in teams that switched to manual ventilation. All teams treated the patient with dantrolene, and symptomatic treatment was initiated by all even though some elements of the full treatment were lacking, possibly due to the limited time available.


CONCLUSIONS
All teams diagnosed MH in the simulator satisfactorily. The surprising negative finding was that more than half of the participants failed to hyperventilate the "patient" although they intended to do so. This investigation shows that the problem in these teams' treatment of MH was more a question of practical management of the resources than lack of theoretical knowledge.
i Gardi
T
T
Department of Anaesthesiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
Christensen
U C
UC
Jacobsen
J
J
Jensen
P F
PF
Ording
H
H
D000776:Anesthesiology / Q000193:education*; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000628:therapy*; D016544:Patient Simulation; D012121:Respiration, Artificial